We've spent the summer working on

• commercially competitive Bio2Amine processes,

• showcasing our tech running routinley in higher TRL reactors, and

• demonstrating a 18-fold improvement in enzyme manufacturing increasing our cost-competitivity across the chemicals sector!

HydRegen’s Bio2Amine technology delivers sustainable, cost-efficient and safe chemical manufacturing with the power of biology: underpinning science published in Nature Communications.

With HydRegen, I was immediately struck not only by the energy and ambition of the team, but also by the potential HydRegen technology has to make a real impact in the pharmaceutical sector and many others. Their innovative biocatalysis technology provides an efficient and sustainable alternative to traditional chemical manufacturing processes, and they have already started to demonstrate real world applications and impact.

HydRegen successfully completes tech transfer to Almac Sciences as part of the joint development project of its proprietary enzyme platform.